124 related articles for article (PubMed ID: 8608970)
1. Serological response to HPV16 in CIN-III and cervical cancer patients. Case-control studies in Spain and Colombia.
De Sanjosé S; Hamsíková E; Muñoz N; Bosch FX; Hofmannová V; Gili M; Izarzugaza I; Viladiu P; Tormo MJ; Moreo P; Muñoz MT; Ascunce N; Tafur L; Shah KV; Vonka V
Int J Cancer; 1996 Mar; 66(1):70-4. PubMed ID: 8608970
[TBL] [Abstract][Full Text] [Related]
2. Serologic response in human papillomavirus-associated invasive cervical cancer.
Viscidi RP; Sun Y; Tsuzaki B; Bosch FX; Muñoz N; Shah KV
Int J Cancer; 1993 Nov; 55(5):780-4. PubMed ID: 8244575
[TBL] [Abstract][Full Text] [Related]
3. Profiling of serum antibodies against human papillomavirus antigens in Korean women with cervical intraepithelial neoplasia and cervical cancer.
Jin Y; Choi JW; Kim HJ; Eddouzi J; Kim SC; Ju W; Kim YH; Kim HJ
Cancer Med; 2018 Nov; 7(11):5655-5664. PubMed ID: 30353680
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma in situ: a case-control study in Spain and Colombia.
Bosch FX; Muñoz N; de Sanjosé S; Navarro C; Moreo P; Ascunce N; Gonzalez LC; Tafur L; Gili M; Larrañaga I
Cancer Epidemiol Biomarkers Prev; 1993; 2(5):415-22. PubMed ID: 8220085
[TBL] [Abstract][Full Text] [Related]
5. Serologic response to human papillomavirus type 16 (HPV-16) virus-like particles in HPV-16 DNA-positive invasive cervical cancer and cervical intraepithelial neoplasia grade III patients and controls from Colombia and Spain.
Nonnenmacher B; Hubbert NL; Kirnbauer R; Shah KV; Muñoz N; Bosch FX; de Sanjosé S; Viscidi R; Lowy DR; Schiller JT
J Infect Dis; 1995 Jul; 172(1):19-24. PubMed ID: 7797910
[TBL] [Abstract][Full Text] [Related]
6. Identification of antibodies against human papillomavirus type 16 E6 and E7 proteins in sera of patients with cervical neoplasias.
Sasagawa T; Inoue M; Tanizawa O; Yutsudo M; Hakura A
Jpn J Cancer Res; 1992 Jul; 83(7):705-13. PubMed ID: 1325428
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer.
Müller M; Viscidi RP; Sun Y; Guerrero E; Hill PM; Shah F; Bosch FX; Muñoz N; Gissmann L; Shah KV
Virology; 1992 Apr; 187(2):508-14. PubMed ID: 1312268
[TBL] [Abstract][Full Text] [Related]
8. Immunologic diagnosis and monitoring of cervical cancers using in vitro translated HPV proteins.
Chee YH; Namkoong SE; Kim DH; Kim SJ; Park JS
Gynecol Oncol; 1995 May; 57(2):226-31. PubMed ID: 7729739
[TBL] [Abstract][Full Text] [Related]
9. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in cervical-carcinoma patients from Russia.
Zumbach K; Kisseljov F; Sacharova O; Shaichaev G; Semjonova L; Pavlova L; Pawlita M
Int J Cancer; 2000 Feb; 85(3):313-8. PubMed ID: 10652419
[TBL] [Abstract][Full Text] [Related]
10. Novel oligomannose liposome-DNA complex DNA vaccination efficiently evokes anti-HPV E6 and E7 CTL responses.
Mizuuchi M; Hirohashi Y; Torigoe T; Kuroda T; Yasuda K; Shimizu Y; Saito T; Sato N
Exp Mol Pathol; 2012 Feb; 92(1):185-90. PubMed ID: 22032938
[TBL] [Abstract][Full Text] [Related]
11. Serum Immune Profiling for Early Detection of Cervical Disease.
Ewaisha R; Panicker G; Maranian P; Unger ER; Anderson KS
Theranostics; 2017; 7(16):3814-3823. PubMed ID: 29109779
[TBL] [Abstract][Full Text] [Related]
12. Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia.
Kadish AS; Ho GY; Burk RD; Wang Y; Romney SL; Ledwidge R; Angeletti RH
J Natl Cancer Inst; 1997 Sep; 89(17):1285-93. PubMed ID: 9293919
[TBL] [Abstract][Full Text] [Related]
13. Serum antibodies to human papillomavirus 16 proteins in women from Brazil with invasive cervical carcinoma.
Sun Y; Eluf-Neto J; Bosch FX; Muñoz N; Walboomers JM; Meijer CJ; Shah KV; Clayman B; Viscidi RP
Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):935-40. PubMed ID: 10548324
[TBL] [Abstract][Full Text] [Related]
14. Presence of antibodies to seven human papillomavirus type 16-derived peptides in cervical cancer patients and healthy controls.
Hamsiková E; Novák J; Hofmannová V; Munoz N; Bosch FX; de Sanjosé S; Shah K; Roth Z; Vonka V
J Infect Dis; 1994 Dec; 170(6):1424-31. PubMed ID: 7995981
[TBL] [Abstract][Full Text] [Related]
15. Comparison of peptide enzyme-linked immunosorbent assay and radioimmunoprecipitation assay with in vitro-translated proteins for detection of serum antibodies to human papillomavirus type 16 E6 and E7 proteins.
Sun Y; Shah KV; Müller M; Muñoz N; Bosch XF; Viscidi RP
J Clin Microbiol; 1994 Sep; 32(9):2216-20. PubMed ID: 7529250
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.
Sathish N; Abraham P; Peedicayil A; Sridharan G; John S; Chandy G
Mol Diagn; 2004; 8(1):57-64. PubMed ID: 15230643
[TBL] [Abstract][Full Text] [Related]
17. Serological response to HPV 16 in cervical dysplasia and neoplasia: correlation of antibodies to E6 with cervical cancer.
Ghosh AK; Smith NK; Stacey SN; Glew SS; Connor ME; Arrand JR; Stern PL
Int J Cancer; 1993 Feb; 53(4):591-6. PubMed ID: 8382193
[TBL] [Abstract][Full Text] [Related]
18. Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide.
Kadish AS; Timmins P; Wang Y; Ho GY; Burk RD; Ketz J; He W; Romney SL; Johnson A; Angeletti R; Abadi M;
Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):483-8. PubMed ID: 12010863
[TBL] [Abstract][Full Text] [Related]
19. Adeno-associated virus seropositivity and HPV-induced cervical cancer in Spain and Colombia.
Smith J; Herrero R; Erles K; Grimm D; Muñoz N; Bosch FX; Tafur L; Shah KV; Schlehofer JR
Int J Cancer; 2001 Nov; 94(4):520-6. PubMed ID: 11745438
[TBL] [Abstract][Full Text] [Related]
20. [Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related lesions--analysis of HPV types 16, 18 E6/E7 gene mRNA].
Nagai N
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):823-33. PubMed ID: 2172419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
